{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:22:11Z","timestamp":1787595731802,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011596","name":"Generalitat of Valencia Ministry of Education Culture Universities and Employment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat of Valencia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejphar.2026.178716","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:21:20Z","timestamp":1772554880000},"page":"178716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Targeting the Keap1-Nrf2 Axis in COPD: Comparative analysis of electrophilic and peptide-based Nrf2 activators in airway and immune cells"],"prefix":"10.1016","volume":"1019","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7741-6600","authenticated-orcid":false,"given":"In\u00e9s","family":"Roger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3054-997X","authenticated-orcid":false,"given":"Cristina","family":"Estornut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Aparici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Albericio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"de Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6033-4211","authenticated-orcid":false,"given":"Javier","family":"Milara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Cortijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178716_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.apsb.2015.05.008","article-title":"Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents","volume":"5","author":"Abed","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2026.178716_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115226","article-title":"Pharmacological characterization of a novel peptide inhibitor of the Keap1-Nrf2 protein-protein interaction","volume":"204","author":"Aparici","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178716_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/152308604771978462","article-title":"Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy","volume":"6","author":"Asikainen","year":"2004","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2026.178716_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00099-20","article-title":"The molecular mechanisms regulating the KEAP1-NRF2 pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.178716_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/cancers2020483","article-title":"Nrf2 and NF-\u03baB and their concerted modulation in cancer pathogenesis and progression","volume":"2","author":"Bellezza","year":"2010","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.178716_bib6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejphar.2026.178716_bib7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1165\/rcmb.2009-0054OC","article-title":"Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation","volume":"42","author":"Blake","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.178716_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.46598","article-title":"Global burden of chronic obstructive pulmonary disease through 2050","volume":"6","author":"Boers","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ejphar.2026.178716_bib9","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1089\/ars.2010.3534","article-title":"Basic principles and emerging concepts in the redox control of transcription factors","volume":"15","author":"Brigelius-Floh\u00e9","year":"2011","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2026.178716_bib10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1476-5381.2008.00041.x","article-title":"Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury","volume":"156","author":"Cortijo","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178716_bib11","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.2147\/OTT.S136992","article-title":"Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors","volume":"10","author":"Creelan","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2026.178716_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/pr.117.014753","article-title":"Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach","volume":"70","author":"Cuadrado","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2026.178716_bib13","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1021\/acs.jmedchem.6b00228","article-title":"Monoacidic inhibitors of the kelch-like ECH-associated protein 1: nuclear factor erythroid 2-Related factor 2 (KEAP1:NRF2) protein-protein interaction with high cell potency identified by fragment-based discovery","volume":"59","author":"Davies","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178716_bib14","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178716_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1465-9921-7-53","article-title":"Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema","volume":"7","author":"Demedts","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejphar.2026.178716_bib16","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1073\/pnas.0500815102","article-title":"Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress","volume":"102","author":"Dinkova-Kostova","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.178716_bib17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2147\/COPD.S51226","article-title":"Oxidative stress and free radicals in COPD \u2013 implications and relevance for treatment","volume":"9","author":"Domej","year":"2014","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.ejphar.2026.178716_bib18","series-title":"Biochemistry and Physiology of the Neutrophil","author":"Edwards","year":"1994"},{"key":"10.1016\/j.ejphar.2026.178716_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s43168-025-00388-0","article-title":"Association between serum interleukin- 6 concentrations, chronic obstructive pulmonary disease, and its relation to severity, acute exacerbation, and its effect on pulmonary function test","volume":"19","author":"Fahyim","year":"2025","journal-title":"Egypt J. Bronchol."},{"key":"10.1016\/j.ejphar.2026.178716_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12931-020-1292-7","article-title":"Oxidative stress and Nrf2 expression in peripheral blood mononuclear cells derived from COPD patients: an observational longitudinal study","volume":"21","author":"Fratta Pasini","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejphar.2026.178716_bib21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.redox.2013.07.005","article-title":"Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-\u03baB pathways in diabetic neuropathy","volume":"1","author":"Ganesh Yerra","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.178716_bib22","unstructured":"GOLD Report, n.d. Global initiative for chronic obstructive lung disease - GOLD. URL https:\/\/goldcopd.org\/2025-gold-report\/(accessed 9.8.25)."},{"key":"10.1016\/j.ejphar.2026.178716_bib23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","article-title":"Nrf2:INrf2 (Keap1) signaling in oxidative stress","volume":"47","author":"Kaspar","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.178716_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026059","article-title":"Human alveolar epithelial cell injury induced by cigarette smoke","volume":"6","author":"Kosmider","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178716_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cbi.2013.12.005","article-title":"Nrf2\/ARE pathway activation, HO-1 and NQO1 induction by polychlorinated biphenyl quinone is associated with reactive oxygen species and PI3K\/AKT signaling","volume":"209","author":"Li","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2026.178716_bib26","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","article-title":"Glutathione synthesis","volume":"1830","author":"Lu","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2026.178716_bib27","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1476-5381.2010.00979.x","article-title":"Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequences","volume":"161","author":"Milara","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178716_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000332834","article-title":"Neutrophil activation in severe, early-onset COPD patients versus healthy non-smoker subjects in vitro: effects of antioxidant therapy","volume":"83","author":"Milara","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.ejphar.2026.178716_bib29","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1476-5381.2012.01929.x","article-title":"Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro","volume":"166","author":"Milara","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178716_bib30","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1476-5381.2012.01929.x","article-title":"Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro","volume":"166","author":"Milara","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178716_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jaci.2014.07.011","article-title":"Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps","volume":"135","author":"Milara","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2026.178716_bib32","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1164\/ajrccm.155.5.9154890","article-title":"Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells","volume":"155","author":"Mio","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2026.178716_bib33","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.3390\/antiox11122345","article-title":"Nrf2 and oxidative stress: a general overview of mechanisms and implications in human disease","volume":"11","author":"Ngo","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.ejphar.2026.178716_bib34","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.2147\/COPD.S475281","article-title":"In vivo and in vitro models of PM2.5 induced COPD: focus on the role of RTA-408","volume":"19","author":"Niu","year":"2024","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.ejphar.2026.178716_bib35","first-page":"347","article-title":"Functional significance of apoptosis in chronic obstructive pulmonary disease","volume":"4","author":"Park","year":"2007","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.ejphar.2026.178716_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122942","article-title":"RTA 408, A novel synthetic triterpenoid with broad anticancer and anti-inflammatory activity","volume":"10","author":"Probst","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178716_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/CBB:43:1:167","article-title":"Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms","volume":"43","author":"Rahman","year":"2005","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2026.178716_bib38","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1172\/JCI200421146","article-title":"Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice","volume":"114","author":"Rangasamy","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.178716_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrneph.2013.13","article-title":"Diabetic nephropathy: could problems with bardoxolone methyl have been predicted?","volume":"9","author":"Rossing","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2026.178716_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuropharm.2013.11.004","article-title":"NRF2-regulation in brain health and disease: implication of cerebral inflammation","volume":"79","author":"Sandberg","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.178716_bib41","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.4049\/jimmunol.172.6.3553","article-title":"Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation","volume":"172","author":"Soares","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2026.178716_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12931-021-01630-1","article-title":"The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD","volume":"22","author":"Song","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejphar.2026.178716_bib43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1165\/ajrcmb.19.5.3091","article-title":"Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells","volume":"19","author":"Su","year":"1998","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.178716_bib44","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1073\/pnas.0804333106","article-title":"Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice","volume":"106","author":"Sussan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.178716_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1165\/rcmb.2007-0424OC","article-title":"Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease","volume":"39","author":"Suzuki","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.178716_bib46","doi-asserted-by":"crossref","first-page":"27258","DOI":"10.1016\/S0021-9258(19)61505-X","article-title":"Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity","volume":"275","author":"Taggart","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178716_bib47","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00214-2017","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary","volume":"49","author":"Vogelmeier","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2026.178716_bib48","first-page":"2075","article-title":"Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties","volume":"8","author":"Wang","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2026.178716_bib49","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.1199","article-title":"Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Wei","year":"2015","journal-title":"PeerJ"},{"key":"10.1016\/j.ejphar.2026.178716_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12890-016-0189-1","article-title":"Impaired nuclear factor erythroid 2-related factor 2 expression increases apoptosis of airway epithelial cells in patients with chronic obstructive pulmonary disease due to cigarette smoking","volume":"16","author":"Yamada","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.ejphar.2026.178716_bib51","first-page":"3203","article-title":"TET1 alleviates cigarette smoke induced bronchial epithelial cell apoptosis through upregulating Nrf2","volume":"20","author":"Zhang","year":"2025","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.ejphar.2026.178716_bib52","doi-asserted-by":"crossref","first-page":"L155","DOI":"10.1152\/ajplung.00449.2016","article-title":"The role of nuclear factor-erythroid 2 related factor 2 (Nrf-2) in the protection against lung injury","volume":"312","author":"Zhao","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926001986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926001986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:53:51Z","timestamp":1779425631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926001986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":52,"alternative-id":["S0014299926001986"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178716","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the Keap1-Nrf2 Axis in COPD: Comparative analysis of electrophilic and peptide-based Nrf2 activators in airway and immune cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178716"}}